✦ LIBER ✦

687 The oral NK1 antagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting: pooled data from 2 randomized, double-blind, placebo controlled trials

✍ Scribed by R. Gralla; P. Hesketh; S. Grunberg; D. Warr; F. Roila; S. Chawla; A. Carides; K. Beck; F. Lawson; K. Horgan

Book ID: 118620859
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 164 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90718-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The oral NK1 antagonist aprepitant for t

The oral NK1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials

✍ David G. Warr; Steven M. Grunberg; Richard J. Gralla; Paul J. Hesketh; Fausto Ro 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 164 KB

O-249 Evaluation of the efficacy and tol

O-249 Evaluation of the efficacy and tolerability of the oral NK1 antagonist aprepitant for the prevention of chemotherapy induced nausea and vomiting: two randomized, double-blind, placebo controlled trials

✍ Gralla, Richard J.; Hesketh, Paul J.; Grunberg, Steven M.; Warr, David G.; Roila 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Establishing the dose of the oral NK1 an

Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting

✍ Sant P. Chawla; Steven M. Grunberg; Richard J. Gralla; Paul J. Hesketh; Cindy Ri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

## Abstract ## BACKGROUND The neurokinin‐1 antagonist aprepitant (EMEND™; Merck Research Laboratories, West Point, PA) has been shown to reduce chemotherapy‐induced nausea and vomiting when it is given with a 5‐hydroxytryptamine‐3 receptor antagonist and dexamethasone. The current study sought to

Addition of the neurokinin 1 receptor an

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting : Results from a randomized, double-blind, placebo-controlled trial in Latin America

✍ Sergio Poli-Bigelli; Jose Rodrigues-Pereira; Alexandra D. Carides; Guoguang Juli 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

Aprepitant triple therapy for the preven

Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial

✍ Hu, Zhihuang; Cheng, Ying; Zhang, Hongyu; Zhou, Caicun; Han, Baohui; Zhang, Yipi 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 347 KB

Olanzapine for the Prevention of Chemoth

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Randomized, Double-Blind, Placebo-Controlled Study

✍ Mizukami, Naomi; Yamauchi, Masanori; Koike, Kazuhiko; Watanabe, Akihiko; Ichihar 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 243 KB